Validation pour Ingenuity376

vers la météo de la validation par utilisateur

Ingenuity376

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 77 - PMID ?

NODE , an agonist of SP NODE protein , is in Phase II clinical trial to treat NODE dependent diabetes mellitus .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

     +--------------------SUBJ:V-N-------------------+                                 +--------------OBJ:V-N--------------+     
     |            +-------COMP:N-N(of)-------+       |                                 |       +-------MOD_ATT:N-ADJ-------+     
     |            |          +-MOD_ATT:N-ADJ-+       +-----------COMP:V-V(to)----------+       |        +----MOD_ATT:N-N---+     
     +----APPOS---+          |       +MOD_ATT+       +COMP:V-N(in+                     |       |        |         +MOD_ATT:+     
     |            |          |       |       |       |           |                     |       |        |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,II)
COMP:V-V(to) (be,treat)
OBJ:V-N (treat,mellitus)
MOD_ATT:N-ADJ (mellitus,__NODE__)
MOD_ATT:N-N (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 1

     +--------------------SUBJ:V-N-------------------+                                 +--------------OBJ:V-N--------------+     
     |            +-------COMP:N-N(of)-------+       |                                 |       +-------MOD_ATT:N-ADJ-------+     
     |            |          +-MOD_ATT:N-ADJ-+       +-----------COMP:V-V(to)----------+       |        +---MOD_ATT:N-ADJ--+     
     +----APPOS---+          |       +MOD_ATT+       +COMP:V-N(in+                     |       |        |         +MOD_ATT:+     
     |            |          |       |       |       |           |                     |       |        |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,II)
COMP:V-V(to) (be,treat)
OBJ:V-N (treat,mellitus)
MOD_ATT:N-ADJ (mellitus,__NODE__)
MOD_ATT:N-ADJ (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 2

                                                     +-----------------------------COMP:V-N(to)----------------------------+     
     +--------------------SUBJ:V-N-------------------+                                 +------------MOD_ATT:N-N------------+     
     |            +-------COMP:N-N(of)-------+       |                                 |       +-------MOD_ATT:N-ADJ-------+     
     |            |          +-MOD_ATT:N-ADJ-+       |                                 |       |        +----MOD_ATT:N-N---+     
     +----APPOS---+          |       +MOD_ATT+       +COMP:V-N(in+                     |       |        |         +MOD_ATT:+     
     |            |          |       |       |       |           |                     |       |        |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,II)
COMP:V-N(to) (be,mellitus)
MOD_ATT:N-N (mellitus,treat)
MOD_ATT:N-ADJ (mellitus,__NODE__)
MOD_ATT:N-N (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 3

                                                     +-----------------------------COMP:V-N(to)----------------------------+     
     +--------------------SUBJ:V-N-------------------+                                 +------------MOD_ATT:N-N------------+     
     |            +-------COMP:N-N(of)-------+       |                                 |       +-------MOD_ATT:N-ADJ-------+     
     |            |          +-MOD_ATT:N-ADJ-+       |                                 |       |        +---MOD_ATT:N-ADJ--+     
     +----APPOS---+          |       +MOD_ATT+       +COMP:V-N(in+                     |       |        |         +MOD_ATT:+     
     |            |          |       |       |       |           |                     |       |        |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,II)
COMP:V-N(to) (be,mellitus)
MOD_ATT:N-N (mellitus,treat)
MOD_ATT:N-ADJ (mellitus,__NODE__)
MOD_ATT:N-ADJ (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 4

                                                     +-----------------------------COMP:V-N(in)----------------------------+     
                                                     |           +-----------------------MOD_ATT:N-N-----------------------+     
                                                     |           |            +-----------------MOD_ATT:N-N----------------+     
     +--------------------SUBJ:V-N-------------------+           |            |        +------------MOD_ATT:N-N------------+     
     |            +-------COMP:N-N(of)-------+       |           |            |        |       +-------MOD_ATT:N-ADJ-------+     
     |            |          +-MOD_ATT:N-ADJ-+       |           |            |        |       |        +----MOD_ATT:N-N---+     
     +----APPOS---+          |       +MOD_ATT+       |           |            |        |       |        |         +MOD_ATT:+     
     |            |          |       |       |       |           |            |        |       |        |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,mellitus)
MOD_ATT:N-N (mellitus,II)
MOD_ATT:N-N (mellitus,trial)
MOD_ATT:N-N (mellitus,treat)
MOD_ATT:N-ADJ (mellitus,__NODE__)
MOD_ATT:N-N (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 5

                                                     +-----------------------------COMP:V-N(in)----------------------------+     
                                                     |           +-----------------------MOD_ATT:N-N-----------------------+     
                                                     |           |            +-----------------MOD_ATT:N-N----------------+     
     +--------------------SUBJ:V-N-------------------+           |            |        +------------MOD_ATT:N-N------------+     
     |            +-------COMP:N-N(of)-------+       |           |            |        |       +-------MOD_ATT:N-ADJ-------+     
     |            |          +-MOD_ATT:N-ADJ-+       |           |            |        |       |        +---MOD_ATT:N-ADJ--+     
     +----APPOS---+          |       +MOD_ATT+       |           |            |        |       |        |         +MOD_ATT:+     
     |            |          |       |       |       |           |            |        |       |        |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,mellitus)
MOD_ATT:N-N (mellitus,II)
MOD_ATT:N-N (mellitus,trial)
MOD_ATT:N-N (mellitus,treat)
MOD_ATT:N-ADJ (mellitus,__NODE__)
MOD_ATT:N-ADJ (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 6

                                                     +-----------------------------COMP:V-N(in)----------------------------+     
                                                     |           +-----------------------MOD_ATT:N-N-----------------------+     
                                                     |           |     +-------------------MOD_ATT:N-ADJ-------------------+     
     +--------------------SUBJ:V-N-------------------+           |     |      +-----------------MOD_ATT:N-N----------------+     
     |            +-------COMP:N-N(of)-------+       |           |     |      |        +------------MOD_ATT:N-N------------+     
     |            |          +-MOD_ATT:N-ADJ-+       |           |     |      |        |                +----MOD_ATT:N-N---+     
     +----APPOS---+          |       +MOD_ATT+       |           |     |      |        |                |         +MOD_ATT:+     
     |            |          |       |       |       |           |     |      |        |                |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,mellitus)
MOD_ATT:N-N (mellitus,II)
MOD_ATT:N-ADJ (mellitus,clinical)
MOD_ATT:N-N (mellitus,trial)
MOD_ATT:N-N (mellitus,treat)
MOD_ATT:N-N (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 7

                                                     +-----------------------------COMP:V-N(in)----------------------------+     
                                                     |      +--------------------------MOD_ATT:N-N-------------------------+     
                                                     |      |    +-----------------------MOD_ATT:N-N-----------------------+     
                                                     |      |    |            +-----------------MOD_ATT:N-N----------------+     
     +--------------------SUBJ:V-N-------------------+      |    |            |        +------------MOD_ATT:N-N------------+     
     |            +-------COMP:N-N(of)-------+       |      |    |            |        |       +-------MOD_ATT:N-ADJ-------+     
     |            |          +-MOD_ATT:N-ADJ-+       |      |    |            |        |       |        +----MOD_ATT:N-N---+     
     +----APPOS---+          |       +MOD_ATT+       |      |    |            |        |       |        |         +MOD_ATT:+     
     |            |          |       |       |       |      |    |            |        |       |        |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,mellitus)
MOD_ATT:N-N (mellitus,phase)
MOD_ATT:N-N (mellitus,II)
MOD_ATT:N-N (mellitus,trial)
MOD_ATT:N-N (mellitus,treat)
MOD_ATT:N-ADJ (mellitus,__NODE__)
MOD_ATT:N-N (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 8

                                                     +-----------------------------COMP:V-N(in)----------------------------+     
                                                     |      +--------------------------MOD_ATT:N-N-------------------------+     
                                                     |      |    +-----------------------MOD_ATT:N-N-----------------------+     
                                                     |      |    |            +-----------------MOD_ATT:N-N----------------+     
     +--------------------SUBJ:V-N-------------------+      |    |            |        +------------MOD_ATT:N-N------------+     
     |            +-------COMP:N-N(of)-------+       |      |    |            |        |       +-------MOD_ATT:N-ADJ-------+     
     |            |          +-MOD_ATT:N-ADJ-+       |      |    |            |        |       |        +---MOD_ATT:N-ADJ--+     
     +----APPOS---+          |       +MOD_ATT+       |      |    |            |        |       |        |         +MOD_ATT:+     
     |            |          |       |       |       |      |    |            |        |       |        |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,mellitus)
MOD_ATT:N-N (mellitus,phase)
MOD_ATT:N-N (mellitus,II)
MOD_ATT:N-N (mellitus,trial)
MOD_ATT:N-N (mellitus,treat)
MOD_ATT:N-ADJ (mellitus,__NODE__)
MOD_ATT:N-ADJ (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 9

                                                     +-----------------------------COMP:V-N(in)----------------------------+     
                                                     |      +--------------------------MOD_ATT:N-N-------------------------+     
                                                     |      |    +-----------------------MOD_ATT:N-N-----------------------+     
                                                     |      |    |     +-------------------MOD_ATT:N-ADJ-------------------+     
     +--------------------SUBJ:V-N-------------------+      |    |     |      +-----------------MOD_ATT:N-N----------------+     
     |            +-------COMP:N-N(of)-------+       |      |    |     |      |        +------------MOD_ATT:N-N------------+     
     |            |          +-MOD_ATT:N-ADJ-+       |      |    |     |      |        |                +----MOD_ATT:N-N---+     
     +----APPOS---+          |       +MOD_ATT+       |      |    |     |      |        |                |         +MOD_ATT:+     
     |            |          |       |       |       |      |    |     |      |        |                |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,mellitus)
MOD_ATT:N-N (mellitus,phase)
MOD_ATT:N-N (mellitus,II)
MOD_ATT:N-ADJ (mellitus,clinical)
MOD_ATT:N-N (mellitus,trial)
MOD_ATT:N-N (mellitus,treat)
MOD_ATT:N-N (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 10

     +--------------------SUBJ:V-N-------------------+                                 +--------------OBJ:V-N--------------+     
     |            +-------COMP:N-N(of)-------+       |                                 |       +-------MOD_ATT:N-ADJ-------+     
     |            |          +-MOD_ATT:N-ADJ-+       +-----------COMP:V-V(to)----------+       |        +----MOD_ATT:N-N---+     
     +----APPOS---+          |       +MOD_ATT+       +COMP:V-N(in+                     |       |        |         +MOD_ATT:+     
     |            |          |       |       |       |           |                     |       |        |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,II)
COMP:V-V(to) (be,treat)
OBJ:V-N (treat,mellitus)
MOD_ATT:N-ADJ (mellitus,__NODE__)
MOD_ATT:N-N (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 11

     +--------------------SUBJ:V-N-------------------+                                 +--------------OBJ:V-N--------------+     
     |            +-------COMP:N-N(of)-------+       |                                 |       +-------MOD_ATT:N-ADJ-------+     
     |            |          +-MOD_ATT:N-ADJ-+       +-----------COMP:V-V(to)----------+       |        +---MOD_ATT:N-ADJ--+     
     +----APPOS---+          |       +MOD_ATT+       +COMP:V-N(in+                     |       |        |         +MOD_ATT:+     
     |            |          |       |       |       |           |                     |       |        |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,II)
COMP:V-V(to) (be,treat)
OBJ:V-N (treat,mellitus)
MOD_ATT:N-ADJ (mellitus,__NODE__)
MOD_ATT:N-ADJ (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 12

                                                     +-----------------------------COMP:V-N(to)----------------------------+     
     +--------------------SUBJ:V-N-------------------+                                 +------------MOD_ATT:N-N------------+     
     |            +-------COMP:N-N(of)-------+       |                                 |       +-------MOD_ATT:N-ADJ-------+     
     |            |          +-MOD_ATT:N-ADJ-+       |                                 |       |        +----MOD_ATT:N-N---+     
     +----APPOS---+          |       +MOD_ATT+       +COMP:V-N(in+                     |       |        |         +MOD_ATT:+     
     |            |          |       |       |       |           |                     |       |        |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,II)
COMP:V-N(to) (be,mellitus)
MOD_ATT:N-N (mellitus,treat)
MOD_ATT:N-ADJ (mellitus,__NODE__)
MOD_ATT:N-N (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 13

                                                     +-----------------------------COMP:V-N(to)----------------------------+     
     +--------------------SUBJ:V-N-------------------+                                 +------------MOD_ATT:N-N------------+     
     |            +-------COMP:N-N(of)-------+       |                                 |       +-------MOD_ATT:N-ADJ-------+     
     |            |          +-MOD_ATT:N-ADJ-+       |                                 |       |        +---MOD_ATT:N-ADJ--+     
     +----APPOS---+          |       +MOD_ATT+       +COMP:V-N(in+                     |       |        |         +MOD_ATT:+     
     |            |          |       |       |       |           |                     |       |        |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,II)
COMP:V-N(to) (be,mellitus)
MOD_ATT:N-N (mellitus,treat)
MOD_ATT:N-ADJ (mellitus,__NODE__)
MOD_ATT:N-ADJ (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 14

                                                     +-----------------------------COMP:V-N(in)----------------------------+     
                                                     |           +-----------------------MOD_ATT:N-N-----------------------+     
                                                     |           |            +-----------------MOD_ATT:N-N----------------+     
     +--------------------SUBJ:V-N-------------------+           |            |        +------------MOD_ATT:N-N------------+     
     |            +-------COMP:N-N(of)-------+       |           |            |        |       +-------MOD_ATT:N-ADJ-------+     
     |            |          +-MOD_ATT:N-ADJ-+       |           |            |        |       |        +----MOD_ATT:N-N---+     
     +----APPOS---+          |       +MOD_ATT+       |           |            |        |       |        |         +MOD_ATT:+     
     |            |          |       |       |       |           |            |        |       |        |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,mellitus)
MOD_ATT:N-N (mellitus,II)
MOD_ATT:N-N (mellitus,trial)
MOD_ATT:N-N (mellitus,treat)
MOD_ATT:N-ADJ (mellitus,__NODE__)
MOD_ATT:N-N (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 15

                                                     +-----------------------------COMP:V-N(in)----------------------------+     
                                                     |           +-----------------------MOD_ATT:N-N-----------------------+     
                                                     |           |            +-----------------MOD_ATT:N-N----------------+     
     +--------------------SUBJ:V-N-------------------+           |            |        +------------MOD_ATT:N-N------------+     
     |            +-------COMP:N-N(of)-------+       |           |            |        |       +-------MOD_ATT:N-ADJ-------+     
     |            |          +-MOD_ATT:N-ADJ-+       |           |            |        |       |        +---MOD_ATT:N-ADJ--+     
     +----APPOS---+          |       +MOD_ATT+       |           |            |        |       |        |         +MOD_ATT:+     
     |            |          |       |       |       |           |            |        |       |        |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,mellitus)
MOD_ATT:N-N (mellitus,II)
MOD_ATT:N-N (mellitus,trial)
MOD_ATT:N-N (mellitus,treat)
MOD_ATT:N-ADJ (mellitus,__NODE__)
MOD_ATT:N-ADJ (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 16

                                                     +-----------------------------COMP:V-N(in)----------------------------+     
                                                     |           +-----------------------MOD_ATT:N-N-----------------------+     
                                                     |           |     +-------------------MOD_ATT:N-ADJ-------------------+     
     +--------------------SUBJ:V-N-------------------+           |     |      +-----------------MOD_ATT:N-N----------------+     
     |            +-------COMP:N-N(of)-------+       |           |     |      |        +------------MOD_ATT:N-N------------+     
     |            |          +-MOD_ATT:N-ADJ-+       |           |     |      |        |                +----MOD_ATT:N-N---+     
     +----APPOS---+          |       +MOD_ATT+       |           |     |      |        |                |         +MOD_ATT:+     
     |            |          |       |       |       |           |     |      |        |                |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,mellitus)
MOD_ATT:N-N (mellitus,II)
MOD_ATT:N-ADJ (mellitus,clinical)
MOD_ATT:N-N (mellitus,trial)
MOD_ATT:N-N (mellitus,treat)
MOD_ATT:N-N (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 17

                                                     +-----------------------------COMP:V-N(in)----------------------------+     
                                                     |      +--------------------------MOD_ATT:N-N-------------------------+     
                                                     |      |    +-----------------------MOD_ATT:N-N-----------------------+     
                                                     |      |    |            +-----------------MOD_ATT:N-N----------------+     
     +--------------------SUBJ:V-N-------------------+      |    |            |        +------------MOD_ATT:N-N------------+     
     |            +-------COMP:N-N(of)-------+       |      |    |            |        |       +-------MOD_ATT:N-ADJ-------+     
     |            |          +-MOD_ATT:N-ADJ-+       |      |    |            |        |       |        +----MOD_ATT:N-N---+     
     +----APPOS---+          |       +MOD_ATT+       |      |    |            |        |       |        |         +MOD_ATT:+     
     |            |          |       |       |       |      |    |            |        |       |        |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,mellitus)
MOD_ATT:N-N (mellitus,phase)
MOD_ATT:N-N (mellitus,II)
MOD_ATT:N-N (mellitus,trial)
MOD_ATT:N-N (mellitus,treat)
MOD_ATT:N-ADJ (mellitus,__NODE__)
MOD_ATT:N-N (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 18

                                                     +-----------------------------COMP:V-N(in)----------------------------+     
                                                     |      +--------------------------MOD_ATT:N-N-------------------------+     
                                                     |      |    +-----------------------MOD_ATT:N-N-----------------------+     
                                                     |      |    |            +-----------------MOD_ATT:N-N----------------+     
     +--------------------SUBJ:V-N-------------------+      |    |            |        +------------MOD_ATT:N-N------------+     
     |            +-------COMP:N-N(of)-------+       |      |    |            |        |       +-------MOD_ATT:N-ADJ-------+     
     |            |          +-MOD_ATT:N-ADJ-+       |      |    |            |        |       |        +---MOD_ATT:N-ADJ--+     
     +----APPOS---+          |       +MOD_ATT+       |      |    |            |        |       |        |         +MOD_ATT:+     
     |            |          |       |       |       |      |    |            |        |       |        |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,mellitus)
MOD_ATT:N-N (mellitus,phase)
MOD_ATT:N-N (mellitus,II)
MOD_ATT:N-N (mellitus,trial)
MOD_ATT:N-N (mellitus,treat)
MOD_ATT:N-ADJ (mellitus,__NODE__)
MOD_ATT:N-ADJ (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)

Analyse 19

                                                     +-----------------------------COMP:V-N(in)----------------------------+     
                                                     |      +--------------------------MOD_ATT:N-N-------------------------+     
                                                     |      |    +-----------------------MOD_ATT:N-N-----------------------+     
                                                     |      |    |     +-------------------MOD_ATT:N-ADJ-------------------+     
     +--------------------SUBJ:V-N-------------------+      |    |     |      +-----------------MOD_ATT:N-N----------------+     
     |            +-------COMP:N-N(of)-------+       |      |    |     |      |        +------------MOD_ATT:N-N------------+     
     |            |          +-MOD_ATT:N-ADJ-+       |      |    |     |      |        |                +----MOD_ATT:N-N---+     
     +----APPOS---+          |       +MOD_ATT+       |      |    |     |      |        |                |         +MOD_ATT:+     
     |            |          |       |       |       |      |    |     |      |        |                |         |        |     
 __NODE__ , an agonist of __SP__ __NODE__ protein , is in Phase II clinical trial to treat __NODE__ dependent diabetes mellitus .
APPOS (__NODE__,agonist)
COMP:N-N(of) (agonist,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,__NODE__)
COMP:V-N(in) (be,mellitus)
MOD_ATT:N-N (mellitus,phase)
MOD_ATT:N-N (mellitus,II)
MOD_ATT:N-ADJ (mellitus,clinical)
MOD_ATT:N-N (mellitus,trial)
MOD_ATT:N-N (mellitus,treat)
MOD_ATT:N-N (mellitus,dependent)
MOD_ATT:N-N (mellitus,diabetes)